γδ T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors

被引:25
作者
Harmon, Cathal [1 ,2 ]
Zaborowski, Alexandra [3 ,4 ]
Moore, Haim [2 ]
St. Louis, Pamela [5 ,6 ]
Slattery, Karen [3 ]
Duquette, Danielle [1 ,2 ,3 ]
Scanlan, John [1 ,2 ,3 ]
Kane, Harry [1 ,2 ,3 ]
Kunkemoeller, Britta [1 ,2 ]
McIntyre, Claire L. [1 ,2 ]
Scannail, Aine Ni [1 ,2 ]
Moran, Bruce [7 ]
Anderson, Ana C. [8 ,9 ,10 ]
Winter, Des [4 ]
Brennan, Donal [11 ]
Brehm, Michael A. [5 ,6 ]
Lynch, Lydia [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Dept Endocrinol, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[3] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland
[4] St Vincents Univ Hosp, Ctr Colorectal Dis, Dublin, Ireland
[5] Univ Massachusetts, Chan Med Sch, Program Mol Med, Worcester, MA USA
[6] Univ Massachusetts, Diabet Ctr Excellence, Chan Med Sch, Worcester, MA USA
[7] St Vincents Univ Hosp, Dept Pathol, Dublin, Ireland
[8] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA USA
[9] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Boston, MA USA
[10] Brigham & Womens Hosp, Boston, MA USA
[11] Univ Coll Dublin, Sch Med, Gynecol Oncol Grp, Dublin, Ireland
基金
美国国家卫生研究院; 爱尔兰科学基金会;
关键词
CONSENSUS MOLECULAR SUBTYPES; IMMUNE CHECKPOINT THERAPY; COLORECTAL-CANCER; EFFECTOR FUNCTION; NKP80; DEFINES; MICROENVIRONMENT; IMMUNOTHERAPY; IMMUNOSCORE; GENERATION; LANDSCAPE;
D O I
10.1038/s43018-023-00589-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lynch and colleagues characterize & gamma;& delta; T cells in colorectal and endometrial cancer and identify distinct subsets with opposing cytotoxic and wound healing functions, leading them to develop an expansion method that enhances cytotoxic functions. & gamma;& delta; T cells are important tissue-resident, innate T cells that are critical for tissue homeostasis. & gamma;& delta; cells are associated with positive prognosis in most tumors; however, little is known about their heterogeneity in human cancers. Here, we phenotyped innate and adaptive cells in human colorectal (CRC) and endometrial cancer. We found striking differences in & gamma;& delta; subsets and function in tumors compared to normal tissue, and in the & gamma;& delta; subsets present in tumor types. In CRC, an amphiregulin (AREG)-producing subset emerges, while endometrial cancer is infiltrated by cytotoxic cells. In humanized CRC models, tumors induced this AREG phenotype in V & delta;1 cells after adoptive transfer. To exploit the beneficial roles of & gamma;& delta; cells for cell therapy, we developed an expansion method that enhanced cytotoxic function and boosted metabolic flexibility, while eliminating AREG production, achieving greater tumor infiltration and tumor clearance. This method has broad applications in cellular therapy as an 'off-the-shelf' treatment option.
引用
收藏
页码:1122 / 1137
页数:31
相关论文
共 50 条
  • [41] Delivery Techniques for Enhancing CAR T Cell Therapy against Solid Tumors
    Fu, Ruxing
    Li, Hongjun
    Li, Ruoxin
    McGrath, Kyle
    Dotti, Gianpietro
    Gu, Zhen
    ADVANCED FUNCTIONAL MATERIALS, 2021, 31 (44)
  • [42] CAR T cell therapy in solid tumors: A review of current clinical trials
    Patel, Urvi
    Abernathy, John
    Savani, Bipin N.
    Oluwole, Olalekan
    Sengsayadeth, Salyka
    Dholaria, Bhagirathbhai
    EJHAEM, 2022, 3 : 24 - 31
  • [43] Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
    Miao, Lele
    Zhang, Zhengchao
    Ren, Zhijian
    Tang, Futian
    Li, Yumin
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [44] Novel approaches to promote CAR T-cell function in solid tumors
    Hull, Caroline M.
    Maher, John
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 789 - 799
  • [45] Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care
    Qin, Shuyang S.
    Melucci, Alexa D.
    Chacon, Alexander C.
    Prieto, Peter A.
    CELLS, 2021, 10 (04)
  • [46] Mesothelin-targeted CAR-T cell therapy for solid tumors
    Klampatsa, Astero
    Dimou, Vivian
    Albelda, Steven M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 473 - 486
  • [47] T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities
    Baeuerle, Patrick A.
    Wesche, Holger
    CURRENT OPINION IN ONCOLOGY, 2022, 34 (05) : 552 - 558
  • [48] Challenges and prospects of chimeric antigen receptor T cell therapy in solid tumors
    Jindal, Vishal
    Arora, Ena
    Gupta, Sorab
    MEDICAL ONCOLOGY, 2018, 35 (06)
  • [49] Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors
    Fan, Jiaqiao
    Das, Jugal Kishore
    Xiong, Xiaofang
    Chen, Hailong
    Song, Jianxun
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [50] Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
    Watanabe, Keisuke
    Kuramitsu, Shunichiro
    Posey, Avery D., Jr.
    June, Carl H.
    FRONTIERS IN IMMUNOLOGY, 2018, 9